SUBSCRIBE
SUBSCRIBE
News   Policy

Takeda Pharmaceutical Co. Ltd. Cracks Down on CMO Plant Suspended After Manufacturing Violation

February 20, 2013 | 
1 min read

Takeda says it will help Nihon Pharmaceuticals bring manufacturing operations up to code after Japanese regulators order the CMO to halt production and recall one lot of its vitamin B1 shot.

Legal Asia
Takeda
MORE ON THIS TOPIC
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Begins Formally Laying Off Employees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Policy
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
Person buried in paperwork hand raised collage art. Man drown in work concept. Overwork illustration for news banner, web articles, and posters
FDA
FDA Rejections: We Read 200 CRLs So You Don’t Have To
July 11, 2025
 · 
5 min read
 · 
Annalee Armstrong